Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Noble Romans (NROM) Cash & Equivalents (2016 - 2025)

Noble Romans has reported Cash & Equivalents over the past 15 years, most recently at $719500.0 for Q3 2025.

  • Quarterly results put Cash & Equivalents at $719500.0 for Q3 2025, up 30.47% from a year ago — trailing twelve months through Sep 2025 was $719500.0 (up 30.47% YoY), and the annual figure for FY2024 was $710227.0, down 18.58%.
  • Cash & Equivalents for Q3 2025 was $719500.0 at Noble Romans, up from $635629.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for NROM hit a ceiling of $2.0 million in Q2 2021 and a floor of $463283.0 in Q1 2023.
  • Median Cash & Equivalents over the past 5 years was $785522.0 (2022), compared with a mean of $942727.5.
  • Biggest five-year swings in Cash & Equivalents: crashed 58.48% in 2022 and later skyrocketed 151.48% in 2024.
  • Noble Romans' Cash & Equivalents stood at $1.3 million in 2021, then tumbled by 37.83% to $785522.0 in 2022, then rose by 11.05% to $872335.0 in 2023, then dropped by 18.58% to $710227.0 in 2024, then increased by 1.31% to $719500.0 in 2025.
  • The last three reported values for Cash & Equivalents were $719500.0 (Q3 2025), $635629.0 (Q2 2025), and $564637.0 (Q1 2025) per Business Quant data.